18 Mar 2021 --- Sweden-based probiotics player BioGaia has equipped a new subsidiary coined BioGaia Invest (BGI) with a total of SEK150 million (US$17.6 million). The investment arm’s long-term strategy is to provide BioGaia with double-digit growth in the upcoming years.
